Factors influencing the effectiveness of recombinant human soluble thrombomodulin on disseminated intravascular coagulation: a retrospective study

Table 3 Cox proportional hazard analysis of some factors of 28-day mortality following rTM treatment

Factors	Adjusted OR	95% CI	p value
Male	1.66	1.065–2.573	0.025
Age≧75	1.57	1.009–2.439	0.046
Sepsis-induced DIC	0.32	0.075–1.369	0.125
Solid tumor-induced DIC	0.54	0.096–3.057	0.487
Trauma-induced DIC	0.45	0.074–2.787	0.393
PT-INR≧1.67	2.23	1.451–3.433	< 0.001
rTM Dose≧380 U/kg	0.95	0.608–1.484	0.820
ATIII co-treatment	0.95	0.598–1.501	0.818
Treatment in ICU	0.91	0.595–1.380	0.645

OR odds ratio, 95%CI 95% confidence interval
ATIII antithrombin III, ICU intensive care unit, PT-INR prothrombin time-international normalized ratio

ISSN: 2055-0294